ACO Name and Location

Independent Physicians ACO, LLC
Previous Names: N/A
1346 Sweetwater Dr
Brentwood, TN 37027

ACO Primary Contact

Primary Contact Name

Rob Bramblett

Primary Contact Phone Number

615-967-6687

Primary Contact Email Address

Rob.bramblett@visualizehealth.co

ACO Organizational Information

ACO Participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

DYNAMIC HEALTH CARE SERVICES, LLC

N

SKYLINE FAMILY PRACTICE PC

N

Lovelace Family Medicine, PA

N

DARYL R DUTTER MD INC

N

James Daley

N

Medcare Associates Pa

N

 

ACO Governing Body:

MemberMember’s Voting Power – Expressed as a percentage or numberMembership TypeACO Participant Legal Business Name/DBA, if Applicable
Last NameFirst NameTitle/Position
FreemanBarbaraChair/Board Member1Community StakeholderN/A
Lovelace. M.D.OscarCMO/Board Member1ACO Participant RepresentativeLovelace Family Medicine, PA
Bradd, M.D.TrippBoard Member1ACO Participant RepresentativeSKYLINE FAMILY PRACTICE PC
Dutter, M.D.DarylBoard Member1ACO Participant RepresentativeDARYL R DUTTER MD INC
Jaafar, M.D.SalehBoard Member1ACO Participant RepresentativeMedcare Associates Pa
Daley, M.D.JamesBoard Member1ACO Participant RepresentativeJames Daley
Barbutti Ronald Board Member 1 Patient Representative N/A
Meyers, M.D.AustinBoard Member1ACO Participant RepresentativeMedcare Associates Pa

 

Key ACO clinical and administrative leadership:

Kenneth Persaud

ACO Executive

Oscar Lovelace

Medical Director

Kenneth Persaud

Compliance Officer

Saleh Jaafar

Quality Assurance/Improvement Officer

 

Associated committees and leadership:

Committee Name

Committee Leader Name and Position

Health Information

Rob Bramblett

Peer Review and Quality Assurance

Dr. Oscar Lovelace, MD.

Patient Advisory

Dr. Oscar Lovelace, MD.

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • N/A

Shared Savings Distribution:

  • N/A

Quality Performance Results

Our ACO did not participate in the Shared Savings Program in the previous performance year, therefore this section is not applicable at this time.

ACO Participation Waiver Disclosure:

The Secretary of U.S. Department of Health and Human Services has provided waivers of certain federal laws that may otherwise limit innovation by ACOs. In accordance with the public disclosure requirements of the ACO Participation Waivers set forth in 80 Fed. Reg. 66725 (Oct. 29, 2015), the applicable arrangements are described below:
 

Medcare Associates, a participating provider within Independent Physicians Accountable Care Organization, LLC has formed an integrated network of health care providers organized for the purposes of improving the quality and efficiency of health care services provided to our patients.   This network of providers has entered into the following arrangements for which waiver protection is sought:

 

Agreement with Quest Diagnostics:  The parties to the arrangement include Medcare Associates (“Medcare”) and Quest Diagnostics Clinical Laboratories, Inc. (“Quest”). The agreement is effective as of April 30, 2019. Under the agreement, the parties will coordinate with each other to meet requirements for reporting quality and cost measures, establish clinical and administrative systems to support chronic disease management and population health strategies, and evaluate and address the health needs of Medcare’s patient population. Quest will make available laboratory testing services to Medcare’s providers, and Medcare will integrate and use this information in Medcare’s data analytics programs, reporting measures, and care coordination and intervention strategies. The agreement includes a series of grants to develop infrastructure and redesigning care processes to allow for high quality and efficient service delivery for patients. This arrangement allows the parties to promote accountability for the quality, cost and overall care for the ACO’s patients and manage and coordinate care for these individuals.

With respect to each of the arrangements above, the ACO’s governing body has made and duly authorized a bona fide determination that the arrangement is reasonably related to the purposes of the Medicare Shared Savings Program.

 

Agreement with PCR Diagnostics:  The parties to the arrangement include Medcare Associates (“Medcare”) and PCR Diagnostics Clinical Laboratories, Inc. (“PCR”). The agreement is effective as of April 30, 2019. Under the agreement, the parties will coordinate with each other to meet requirements for reporting quality and cost measures, establish clinical and administrative systems to support acute respiratory and gastrointestinal diagnostic testing, including the mitigation of unnecessary antibiotic prescription within Medcare’s patient population.  PCR will make available laboratory testing services to Medcare’s providers, and Medcare will integrate and use this information in Medcare’s data analytics programs, reporting measures, and care coordination and intervention strategies. The agreement includes a series of grants to develop infrastructure and redesigning care processes to allow for high quality and efficient service delivery for patients. This arrangement allows the parties to promote accountability for the quality, cost and overall care for the ACO’s patients and manage and coordinate care for these individuals.

With respect to each of the arrangements above, the ACO’s governing body has made and duly authorized a bona fide determination that the arrangement is reasonably related to the purposes of the Medicare Shared Savings Program.